Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
AIBD Regionals April NC
Session V: What’s New In 2022: Case-Based
What’s New In 1st Line Therapy In 2022
Saturday, April 2, 2022
4:30 PM – 4:50 PM
Speaker(s)
David P. Hudesman, MD, FACG, AGAF
NYU Langone Health
New York, New York
This session is supported by an independent educational grant from Bristol Myers Squibb.
Learning Objectives:
Summarize key efficacy and safety data for new and emerging S1P receptor modulators in the treatment of IBD
Leverage the benefits of S1P receptor modulator treatment in appropriate patients with UC